expressed RNAi
The company also announced deals for new DNA production and delivery technologies.
NEW YORK (GenomeWeb) – Benitec Biopharma this week announced that it has licensed its expressed RNAi technology to Circuit Therapeutics for the development of an intractable pain treatment.
NEW YORK (GenomeWeb) – Benitec Biopharma said this week that laboratory data on the first patient dosed in its Phase I/IIa trial its expressed RNAi treatment for hepatitis C indicate that the drug is safe and well tolerated.
NEW YORK (GenomeWeb) – Benitec Biopharma this week announced that it is appealing the European Patent Office's recent revocation of a patent covering the company's core expressed RNAi technology, which had been successfully challenged by biotech firm Galapagos and agro-chemical giant BASF.
NEW YORK (GenomeWeb) – Benitec Biopharma last week disclosed delays in its efforts to dose patients in a Phase I/IIa trial of its expressed RNAi-based hepatitis C treatment TT-034 and said that it is taking steps to speed subject enrollment.
Jul 3, 2014
May 29, 2014
Nov 21, 2013
Sep 12, 2013
Jul 11, 2013
Jun 13, 2013
Jun 6, 2013
Apr 25, 2013
Apr 18, 2013
Apr 18, 2013
Apr 11, 2013
Apr 11, 2013
People in the News: Kevin Buchi
Premium
Apr 4, 2013
Mar 28, 2013
Mar 7, 2013
Nov 8, 2012
Nov 8, 2012
Oct 18, 2012